Study of LW231 in Participants With Chronic Hepatitis B

NCT07179575 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic HBV Infection

Interventions

DRUG: LW231
DRUG: LW231 placebo

Sponsor

Shanghai Longwood Biopharmaceuticals Co., Ltd.